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In the acute hospital setting the COVID-19 pandemic presents 
some unique challenges to acute patient care. These include 
accurate recognition of cases, confirmation of both testing 
requests and results, establishing patient acuity and alerting 
to deterioration. We report our experience introducing a digital 
COVID-19 assessment tool with an associated live dashboard 
at two acute NHS hospitals, enabling accurate hospital-level 
reporting alongside risk stratification.
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Introduction 
The COVID-19 pandemic caused by the novel severe acute 
respiratory syndrome coronavirus SARS-CoV-2 is a global healthcare 
emergency.1 Since the first described cases in the UK at the end 
of January 2020, the NHS has had to respond rapidly to this 
new disease.2 At our hospital trust it was clear, following initial 
experience, that accurate reporting and hospital-wide visualisation 
of patients with suspected and confirmed COVID-19 would be 
crucial for the optimal management of our local response. This brief 
report outlines the steps taken to provide a digital real-time overview 
of our caseload. 
Up until the end of March, testing for our population was 
performed at another trust with a turnaround time in days. The 
majority of COVID-19 swab samples were performed by emergency 
department (ED) staff and sent to the laboratory to be ‘booked 
in’ and dispatched to the testing site. Out of hours there was the 
potential for delays in visualisation of ‘booking in’ status and of test 
results. Although the number of tests and those positive could be 
reviewed on a trust level, this was not in a ‘live’ format. 
Interventions
For a number of years, the Trust has used the track-and-trigger 
system Patientrack Alcidionâ for real-time electronic physiological 
observations and other assessments, such as frailty, malnutrition 
and dementia. This platform was utilised to rapidly produce a 
mandatory COVID-19 assessment to be completed by nursing 
staff at the point of admission to hospital (as the ED team work on 
paper charting), produced in consultation with our microbiology 
and infection control team. All patients receive the admission 
assessment and, for those not suspected of having COVID-19, a 
single click selection of the ‘not suspected’ field is all that is required. 
We employed recommended methods for clinical decision support 
to optimise compliance and avoid undue disruption to the clinical 
workflow.3 Fig 1 shows the assessment within the Patientrack 
architecture. This includes a prompt to complete a frailty assessment 
as per NICE guidance.4 
Live dashboard report with physiological  
risk stratification
To enable hospital-wide visualisation of patients suspected and 
confirmed to have COVID, a live dashboard was created. Once 
the COVID-19 assessment is submitted, the patient details are 
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Fig 1. Individual COVID-19 assessment interface. This is accessed from 
the individual patient tile; once submitted the patient is automatically 
transferred into the live dashboard COVID-19 report.
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automatically entered into the dashboard, which then automatically 
updates once a COVID-19 result is returned through the laboratory 
reporting system (Fig 2).
Early reports from China suggest that COVID-19 may necessitate 
more nuanced ways of highlighting those at highest risk, with the 
performance of traditional scoring systems such as the National 
Early Warning Score 2 (NEWS-2) as yet unclear. For example, blood 
pressure, heart rate and temperature do not differ significantly 
between those with severe and non-severe disease.5–7 To date, 
there are no recommended prediction models to help stratify risk, 
with a systematic review finding all prognostic models at high risk 
of bias.8 However, previous studies have suggested that the ratio 
of oxygen saturations to (approximate) concentration of oxygen 
delivered (SpO
2
:FiO
2
) is a good surrogate of the PaO
2
:FiO
2
 used 
in the critical care environment,9,10 and could potentially be used 
as an electronically calculated variable to alert clinical teams to 
deterioration. SpO
2
:FiO
2 
values have been proposed11 as:  
 > 235–314: mild impairment
 > 150–234: moderate impairment
 > <150: severe impairment.
A further enhancement of respiratory risk stratification could 
include the respiratory rate ([SpO
2
:FiO
2
]/respiratory rate), termed 
the ROX score, which has been derived and externally validated to 
predict failure of nasal high flow therapy (defined as requirement 
for intubation).12,13 A value >4.88 predicts those less likely to 
require intubation. We have employed a colour-coded system 
(yellow, amber, red) to highlight patients with extremes of 
respiratory dysfunction using both of these methods, which can aid 
visualisation of patients in the busy clinical environment (Fig 2). 
Numerous other scores in this area include the Murray score, 
described in 1988, which comprises quadrants infiltrated on the 
chest radiograph, degree of hypoxaemia, positive end-expiratory 
pressure (PEEP) and static compliance of the respiratory system.14 
The Murray score is more suitable for critical care patients – for 
example, those undergoing consideration for extracorporeal 
membrane oxygenation (ECMO) – as is the respiratory 
extracorporeal membrane oxygenation survival prediction 
(RESP) score.15 The MuLBSTA score was published last year from 
a Chinese viral pneumonia cohort, and comprises multi-lobar 
infiltrates, lymphopenia, bacterial co-infection, current or ex-smoker, 
hypertension and age; however, this score has limited validation.16
Education and awareness
On the basis of previous experience in introducing assessments, 
we used a combination of Trust communications (email and paper 
‘Weekly headlines’, ‘Theme of the week’, and desktop alerting), 
daily staff huddles, and meetings with doctors and nurses and the 
outreach nursing team on both acute hospital sites. An iterative 
process was employed to optimise completion and clinical utility. 
Issues and feedback 
As with any IT implementation project, user input was crucial to 
ensure acceptability and success. Firstly, following feedback from 
clinical teams, the assessment was significantly shortened to the 
current version, having previously had additional information 
requirements, including reporting of symptoms and whether other 
investigations had been performed. Secondly, as doctors at our Trust 
predominantly use a separate e-handover system for their clinical 
workflow, a second solution was developed in tandem to display 
information regarding COVID samples for clinical visualisation 
within the clinical portal (Fig 3). Thirdly, if a patient were to develop 
new symptoms on the ward prompting investigation for COVID-19, 
the ward team would have to complete a second digital assessment 
as the initial admission assessment would place the patient in 
the ‘COVID not suspected’ cohort. This has required ongoing 
education by the outreach clinical teams. Between go-live on the 23 
March 2020 and 9 April 2020, 1,270 patients had an assessment 
performed, with a positive response from ward and outreach clinical 
teams to the package that has been introduced. In addition, a 
system of ensuring clear documentation of investigations requested 
by the ED team was required to prevent duplication or omission; 
this system rapidly evolved from a stamp on the front of the paper 
clerking notes to a bespoke COVID-19 ED clerking proforma. 
Conclusions
We describe a simple digital COVID-19 assessment that has 
provided our clinical teams and hospital management with up-to-
date information during a rapidly changing clinical situation.  
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Fig 2. COVID-19 report interface. This live dashboard highlights location of 
patient, test status (suspected, awaiting test, confirmed), latest physiological 
variables and clinical frailty scale assessment.
Fig 3. Clinical portal used by the clinical team. COVID-19 swab status is 
included as part of handover and task management.
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